These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 8072836)

  • 1. Role of antibody and the use of respiratory syncytial virus immunoglobulin in the prevention of respiratory syncytial virus disease in preterm infants with and without bronchopulmonary dysplasia.
    Groothuis JR
    Pediatr Infect Dis J; 1994 May; 13(5):454-7; discussion 457-8. PubMed ID: 8072836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Respiratory syncytial virus (RSV) infection in preterm infants and the protective effects of RSV immune globulin (RSVIG). Respiratory Syncytial Virus Immune Globulin Study Group.
    Groothuis JR; Simoes EA; Hemming VG
    Pediatrics; 1995 Apr; 95(4):463-7. PubMed ID: 7700741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of antibody and use of respiratory syncytial virus (RSV) immune globulin to prevent severe RSV disease in high-risk children.
    Groothuis JR
    J Pediatr; 1994 May; 124(5 Pt 2):S28-32. PubMed ID: 8169755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections: Respiratory Syncytial Virus Immune Globulin Study Group.
    Rodriguez WJ; Gruber WC; Welliver RC; Groothuis JR; Simoes EA; Meissner HC; Hemming VG; Hall CB; Lepow ML; Rosas AJ; Robertsen C; Kramer AA
    Pediatrics; 1997 Mar; 99(3):454-61. PubMed ID: 9041304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Respiratory syncytial virus immunoglobulin and monoclonal antibodies in the prevention and treatment of respiratory syncytial virus infection.
    Welliver RC
    Semin Perinatol; 1998 Feb; 22(1):87-95. PubMed ID: 9523402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prophylaxis of respiratory syncytial virus (RSV) in preterm infants with/without bronchopulmonary dysplasia: hyperimmune globulin (RSV-IGIV) and palivizumab (MEDI-493)].
    Resch B; Müller W
    Klin Padiatr; 1999; 211(6):450-5. PubMed ID: 10592925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylaxis for respiratory syncytial virus with respiratory syncytial virus-immunoglobulin intravenous among preterm infants of thirty-two weeks gestation and less: reduction in incidence, severity of illness and cost.
    Atkins JT; Karimi P; Morris BH; McDavid G; Shim S
    Pediatr Infect Dis J; 2000 Feb; 19(2):138-43. PubMed ID: 10694001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of respiratory syncytial virus hospitalization among premature infants and infants with bronchopulmonary dysplasia using respiratory syncytial virus immune globulin prophylaxis. The PREVENT Study Group.
    Pediatrics; 1997 Jan; 99(1):93-9. PubMed ID: 8989345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoglobulin for preventing respiratory syncytial virus infection.
    Wang EE; Tang NK
    Cochrane Database Syst Rev; 2000; (2):CD001725. PubMed ID: 10796658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lower respiratory tract illness and RSV prophylaxis in very premature infants.
    Lacaze-Masmonteil T; Truffert P; Pinquier D; Daoud P; Goldfarb G; Vicaut E; Fauroux B
    Arch Dis Child; 2004 Jun; 89(6):562-7. PubMed ID: 15155404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group.
    Groothuis JR; Simoes EA; Levin MJ; Hall CB; Long CE; Rodriguez WJ; Arrobio J; Meissner HC; Fulton DR; Welliver RC
    N Engl J Med; 1993 Nov; 329(21):1524-30. PubMed ID: 8413475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group.
    Pediatrics; 1998 Sep; 102(3 Pt 1):531-7. PubMed ID: 9738173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WITHDRAWN: Immunoglobulin for preventing respiratory syncytial virus infection.
    Wang EE; Tang NK
    Cochrane Database Syst Rev; 2007 Jul; 2006(3):CD001725. PubMed ID: 17636681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Respiratory syncytial virus-enriched globulin for the prevention of acute otitis media in high risk children.
    Simoes EA; Groothuis JR; Tristram DA; Allessi K; Lehr MV; Siber GR; Welliver RC
    J Pediatr; 1996 Aug; 129(2):214-9. PubMed ID: 8765618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of serious respiratory syncytial virus-related illness. II: Immunoprophylaxis.
    Groothuis JR; Hoopes JM; Hemming VG
    Adv Ther; 2011 Feb; 28(2):110-25. PubMed ID: 21318605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety, tolerance and pharmacokinetics of a humanized monoclonal antibody to respiratory syncytial virus in premature infants and infants with bronchopulmonary dysplasia. MEDI-493 Study Group.
    Subramanian KN; Weisman LE; Rhodes T; Ariagno R; Sánchez PJ; Steichen J; Givner LB; Jennings TL; Top FH; Carlin D; Connor E
    Pediatr Infect Dis J; 1998 Feb; 17(2):110-5. PubMed ID: 9493805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Respiratory syncytial virus immune globulin intravenous: indications for use. American Academy of Pediatrics Committee on Infectious Diseases, Committee on Fetus and Newborn.
    Pediatrics; 1997 Apr; 99(4):645-50. PubMed ID: 9093323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for severe respiratory syncytial virus infection in infants.
    Aujard Y; Fauroux B
    Respir Med; 2002 Apr; 96 Suppl B():S9-14. PubMed ID: 11996403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Product review on the monoclonal antibody palivizumab for prevention of respiratory syncytial virus infection.
    Resch B
    Hum Vaccin Immunother; 2017 Sep; 13(9):2138-2149. PubMed ID: 28605249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and bioequivalency of three formulations of respiratory syncytial virus-enriched immunoglobulin.
    Groothuis JR; Simoes EA; Lehr MV; Kramer AA; Hemming VG; Rodriguez WJ; Arrobio J; Welliver RC; Siber GR
    Antimicrob Agents Chemother; 1995 Mar; 39(3):668-71. PubMed ID: 7793870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.